News and views
Our magazine
Insights gives you all the news from the labs, hot topics, health tips and personal stories. Available as a free monthly email or twice-yearly magazine.
Sign up for more news and viewsNew evidence for world's first ever precision medicine for prostate cancer
Today, results released at the ESMO 2019 conference in Barcelona showed targeted breast and ovarian cancer drug olaparib could slow the progression of advanced prostate cancer. Find out how these advances are set to transform men’s lives.
Research blog: The jigsaw is falling into place but one crucial piece is missing
BLOG: From 'seek and destroy' radiotherapy to repurposing an ovarian cancer drug, it's been a week of big news from the world's biggest cancer research conference. Dr Matthew Hobbs gives his perspective on the latest in prostate cancer and what needs to happen next.
Quicker, stronger, personalised and targeted: the cutting edge of research into better treatments
BLOG: Dr Matthew Hobbs, our Acting Director of Research, shares his highlights from the latest research into more effective treatments for men with prostate cancer.
The oxygen-boosting precision medicine that could make radiotherapy work for more men
BLOG: Our research comms officer, Ruby Kell, explains how a promising new test we're funding could help identify men whose radiotherapy is likely to fail, then target them with a commonly-used drug that will stop the treatment from being thwarted.
"Dad would be over the moon about the new research – you need hope going up against prostate cancer"
Hayley Yarnley knows how much our new precision medicine research programme could have helped her father, Bernie, who died from advanced prostate cancer last December. She describes how the births of her children kept him going during his treatment, and why he was convinced scientists would one day find a cure.
Early research shows immunotherapy's potential for one type of aggressive prostate cancer
The Institute of Cancer Research has discovered a genetic mutation in samples of some men's tumours that could make them particularly susceptible to immunotherapy treatment. The researchers are now committed to running clinical trials to prove if their theory is right.
Ovarian cancer drug could help more men with prostate cancer than first thought
A new study suggests olaparib could boost the efficacy of treatment for earlier-stage prostate cancer, after discovering how it can block the repair of DNA in cancer cells no matter what kind of the disease they have.
The art of precision medicine
Prostate cancer is finally catching up with similar diseases in having treatments that can target an individual’s specific cancer – and it’s thanks to the game-changing research that you help us fund.
What a difference a year in research makes
BLOG: We're only 12 months into our ten-year strategy to tame prostate cancer, but that doesn't mean we haven't already made exciting progress. Our resident expert, Dr Ian Le Guillou, gives us his top ten biggest research breakthroughs (in no particular order) from 2016.
Two new research grants hope to make liquid biopsies a clinical reality
Two research projects, using cutting-edge liquid biopsy technology to help improve diagnosis and treatment of men with prostate cancer, have been awarded funds by Prostate Cancer UK with the hope they'll used with real patients in the near future.